In this study, we utilized the human brain endothelial cell line, hCMEC/D3, to determine the effects of the coagulation factor, thrombin, on the human blood-brain barrier (BBB). We show that thrombin increased the mRNA and cell surface levels of ICAM-1 and VCAM-1 in hCMEC/D3 cells. Thrombin similarly upregulated several chemokines implicated in human neurological conditions. Additionally, the paracellular permeability of the human BBB in vitro was also increased following thrombin treatment. Overall, this study demonstrates that thrombin can effectively induce an inflamed phenotype in an in vitro human BBB.
Introduction
The blood-brain barrier (BBB) is structured to limit the influx of potentially harmful blood-borne molecules into the central nervous system (CNS). The BBB endothelium, however, is responsive to various stimuli resulting in a BBB phenotype that can dynamically change based on the conditions in the microenvironment (de Boer and Gaillard, 2006) . In neuroinflammatory settings, for instance, an inflamed BBB becomes more permeable to leukocytes in the circulation as a consequence of phenotypic changes that include the disassembly of tight junction molecules, increased expression of cell adhesion molecules (CAMs), and synthesis of chemotactic molecules (Webb and Muir, 2000; de Boer and Gaillard, 2006) .
In recent years, there has been accumulating evidence of a complex, two-way interaction between the immune and coagulation systems (Levi and van der Poll, 2005; Esmon, 2008) . Specific components of the coagulation system can directly influence the immune response. The coagulation factor, thrombin, in particular, is widely-regarded to have a major influence on inflammation (Naldini et al., 2002; Szaba and Smiley, 2002; Yanagita et al., 2007) . Thrombin is a serine protease that is responsible for the formation of fibrin, the primary component of blood clot (Monroe and Hoffman, 2006) . Beyond its central role in the coagulation process, thrombin can directly affect the cellular processes of various cell types, including leukocytes and endothelial cells, largely through the activation of G protein-coupled receptors known as protease-activated receptors (PARs) (Coughlin, 1999; Derian et al., 2002) .
While the inflammatory influences of thrombin have been predominantly observed in the periphery, there are now growing reports that thrombin may also be involved in neuroinflammatory and neurodegenerative conditions (Chapman, 2006; Sokolova and Reiser, 2008) . Thrombin in the circulation can enter the CNS in conditions where the BBB is compromised (Suo et al., 2004) . Additionally several coagulation factors including prothrombin and its activator, factor X, are locally synthesized in the brain (Dihanich et al., 1991; Yamada and Nagai, 1996) . Increased thrombin activity and/or expression in the CNS have been observed in a number of neurological diseases. In Parkinson's disease and human immunodeficiency virus encephalitis, thrombin and prothrombin expression have been shown to be upregulated in astrocytes and neurons (Boven et al., 2003; Ishida et al., 2006) . Ischemic brains are characterized by high thrombin levels as a result of thrombin extravasation from the circulation and local prothrombin synthesis (Riek-Burchardt et al., 2002; de Castro Ribeiro et al., 2006) . Elevated thrombin levels have also been observed in brain microvessels in Alzheimer's disease (Grammas et al., 2006) . While the specific role of thrombin in the progression of these diseases is still not welldelineated, it is known that resident cells in the CNS can be responsive to thrombin activity. Thrombin can induce microglia and astrocytes to release proinflammatory cytokines including IL-1β, IL-6, and TNF-α (Choi et al., 2003; Ishida et al., 2006) . High thrombin concentrations can also result in neurodegeneration (Rohatgi et al., 2004) .
Similarly, in vivo studies in animal models have shown that the BBB can be responsive to high levels of thrombin in the CNS. For instance, intrathecal injection of thrombin into rat brains can result in brain edema as a result of BBB permeability (Chen et al., 2010; Liu et al., 2010) . The collective effects of thrombin on the phenotype of the specialized endothelial cells that comprise the human BBB however have not been thoroughly investigated. While there are a number of studies that have examined thrombin's effects on endothelial Journal of Neuroimmunology 245 (2012) [48] [49] [50] [51] [52] [53] [54] [55] 
